Sanford Hillsberg Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sanford Hillsberg.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sanford Hillsberg. Sanford Hillsberg is 10% Owner in Cordex Pharma, Inc. ($DSKT) and Secretary in Cordex Pharma, Inc. ($DSKT) and Director in Galena Biopharma, Inc. ($GALE) and Director in Lion Biotechnologies, Inc. ($LBIO).
Latest Insider Trading Transactions of Sanford Hillsberg
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DSKT, IOVA, SLS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 29 2015 | LBIO | Lion Biotechnologi ... | Hillsberg Sanford | Director | Option Exercise | J | 2.50 | 25,000 | 62,500 | 0 | |
Jan 29 2015 | LBIO | Lion Biotechnologi ... | Hillsberg Sanford | Director | Option Exercise | A | 2.50 | 25,000 | 62,500 | 25,000 | |
Jan 29 2015 | LBIO | Lion Biotechnologi ... | Hillsberg Sanford | Director | Sell | J | 0.00 | 25,000 | 0 | 0 | 25 K to 0 (-100.00 %) |
Jan 29 2015 | LBIO | Lion Biotechnologi ... | Hillsberg Sanford | Director | Grant | A | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
Mar 05 2014 | LBIO | Lion Biotechnologi ... | Hillsberg Sanford | Director | Option Exercise | A | 5.65 | 40,000 | 226,000 | 40,000 | |
Jan 16 2014 | LBIO | Lion Biotechnologi ... | Hillsberg Sanford | Director | Grant | A | 0.00 | 67,500 | 0 | 269,000 | 201.5 K to 269 K (+33.50 %) |
Jan 31 2014 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Option Exercise | H | 1.71 | 50,000 | 85,500 | 0 | |
Jan 31 2014 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Option Exercise | M | 1.18 | 100,000 | 118,000 | 0 | |
Jan 31 2014 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Option Exercise | M | 1.18 | 100,000 | 118,000 | 0 | |
Jan 31 2014 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Gift | G | 0.00 | 15,000 | 0 | 95,447 | 110.4 K to 95.4 K (-13.58 %) |
Jan 31 2014 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Sell | S | 5.41 | 250,000 | 1,352,500 | 17,974 | 268 K to 18 K (-93.29 %) |
Jan 31 2014 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Buy | M | 1.71 | 50,000 | 85,500 | 267,974 | 218 K to 268 K (+22.94 %) |
Jan 31 2014 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Buy | M | 1.18 | 200,000 | 236,000 | 217,974 | 18 K to 218 K (+1,112.72 %) |
Jan 22 2014 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Sell | S | 6.93 | 200,000 | 1,385,000 | 110,447 | 310.4 K to 110.4 K (-64.42 %) |
Jan 16 2014 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Option Exercise | M | 0.85 | 200,000 | 170,000 | 0 | |
Jan 16 2014 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Payment of Exercise | F | 6.96 | 24,426 | 170,005 | 310,447 | 334.9 K to 310.4 K (-7.29 %) |
Jan 16 2014 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Buy | M | 0.85 | 200,000 | 170,000 | 334,873 | 134.9 K to 334.9 K (+148.29 %) |
Nov 07 2013 | LBIO | Lion Biotechnologi ... | Hillsberg Sanford | Director | Grant | A | 0.00 | 67,500 | 0 | 201,500 | 134 K to 201.5 K (+50.37 %) |
Dec 13 2013 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Option Exercise | M | 0.72 | 50,000 | 36,000 | 0 | |
Dec 13 2013 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Payment of Exercise | F | 4.19 | 8,592 | 36,000 | 134,873 | 143.5 K to 134.9 K (-5.99 %) |
Dec 13 2013 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Buy | M | 0.72 | 50,000 | 36,000 | 143,375 | 93.4 K to 143.4 K (+53.55 %) |
Dec 13 2013 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Gift | G | 0.00 | 37,001 | 0 | 93,375 | 130.4 K to 93.4 K (-28.38 %) |
Nov 27 2013 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Option Exercise | A | 3.88 | 200,000 | 776,000 | 200,000 | |
Oct 15 2013 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Grant | A | 0.00 | 2,630 | 0 | 17,974 | 15.3 K to 18 K (+17.14 %) |
Jun 13 2013 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Grant | A | 0.00 | 9,327 | 0 | 145,703 | 136.4 K to 145.7 K (+6.84 %) |
Jul 10 2012 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Grant | A | 0.00 | 31,966 | 0 | 156,376 | 124.4 K to 156.4 K (+25.69 %) |
Jan 05 2007 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.05 | 12,500 | 563 | 3,158,000 | 3.2 M to 3.2 M (-0.39 %) |
Oct 25 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.09 | 50,000 | 4,500 | 3,170,500 | 3.2 M to 3.2 M (-1.55 %) |
Sep 07 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.10 | 10,000 | 1,000 | 3,220,500 | 3.2 M to 3.2 M (-0.31 %) |
Sep 07 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.11 | 6,400 | 704 | 3,230,500 | 3.2 M to 3.2 M (-0.20 %) |
Aug 04 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.11 | 7,200 | 792 | 3,236,900 | 3.2 M to 3.2 M (-0.22 %) |
Aug 04 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.11 | 7,000 | 770 | 3,244,100 | 3.3 M to 3.2 M (-0.22 %) |
Jul 27 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.09 | 10,000 | 900 | 3,251,100 | 3.3 M to 3.3 M (-0.31 %) |
Jul 18 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.16 | 10,000 | 1,600 | 3,261,100 | 3.3 M to 3.3 M (-0.31 %) |
Jul 12 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.16 | 30,000 | 4,800 | 3,271,100 | 3.3 M to 3.3 M (-0.91 %) |
Jul 12 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.15 | 15,000 | 2,250 | 3,301,100 | 3.3 M to 3.3 M (-0.45 %) |
Jul 12 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.16 | 5,000 | 800 | 3,316,100 | 3.3 M to 3.3 M (-0.15 %) |
Jun 29 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.21 | 25,000 | 5,250 | 3,321,100 | 3.3 M to 3.3 M (-0.75 %) |
Jun 29 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.26 | 10,000 | 2,600 | 3,346,100 | 3.4 M to 3.3 M (-0.30 %) |
Jun 15 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.33 | 5,000 | 1,650 | 3,336,100 | 3.3 M to 3.3 M (-0.15 %) |
Jun 15 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.30 | 5,000 | 1,500 | 3,341,100 | 3.3 M to 3.3 M (-0.15 %) |
Jun 12 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.40 | 5,000 | 2,005 | 3,346,100 | 3.4 M to 3.3 M (-0.15 %) |
Jun 12 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.41 | 20,000 | 8,100 | 3,351,100 | 3.4 M to 3.4 M (-0.59 %) |
Jun 12 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.41 | 5,000 | 2,050 | 3,371,100 | 3.4 M to 3.4 M (-0.15 %) |
Jun 12 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.41 | 15,000 | 6,075 | 3,376,100 | 3.4 M to 3.4 M (-0.44 %) |
Jun 12 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.41 | 5,000 | 2,050 | 3,391,100 | 3.4 M to 3.4 M (-0.15 %) |
Jun 06 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.41 | 10,000 | 4,100 | 3,396,100 | 3.4 M to 3.4 M (-0.29 %) |
Jun 06 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.45 | 15,000 | 6,750 | 3,406,100 | 3.4 M to 3.4 M (-0.44 %) |
Jun 06 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.46 | 5,000 | 2,300 | 3,421,100 | 3.4 M to 3.4 M (-0.15 %) |
Jun 06 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.47 | 5,000 | 2,350 | 3,426,100 | 3.4 M to 3.4 M (-0.15 %) |
Jun 01 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.45 | 14,000 | 6,300 | 3,431,100 | 3.4 M to 3.4 M (-0.41 %) |
Jun 01 2006 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | 10% Owner | Sell | S | 0.50 | 3,500 | 1,750 | 3,445,100 | 3.4 M to 3.4 M (-0.10 %) |
Jun 23 2005 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | Secretary | Option Exercise | G | 2.20 | 20,000 | 44,000 | 20,000 | |
May 02 2005 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | Secretary | Gift | G | 0.00 | 25,000 | 0 | 3,498,600 | 3.5 M to 3.5 M (-0.71 %) |
Apr 21 2005 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | Secretary | Gift | G | 0.00 | 30,000 | 0 | 3,523,600 | 3.5 M to 3.5 M (+0.86 %) |
Mar 02 2005 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | Secretary | Option Exercise | A | 2.20 | 40,000 | 88,000 | 40,000 | |
Jan 28 2005 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | Secretary | Gift | G | 0.00 | 100,000 | 0 | 3,553,600 | 3.7 M to 3.6 M (-2.74 %) |
Oct 18 2004 | DSKT | Cordex Pharma, Inc ... | Hillsberg Sanford | Secretary | Gift | G | 0.00 | 100,000 | 0 | 3,653,600 | 3.8 M to 3.7 M (-2.66 %) |
Page: 1